Scientists use artificial gut to study kidney toxins
NCT ID NCT04768309
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how gut bacteria in people with chronic kidney disease (CKD) produce harmful toxins that build up in the body. Researchers collected stool samples from 20 patients with advanced CKD and placed them into an artificial intestine to test whether probiotics could reduce toxin production. The goal was to understand the process better, not to treat patients directly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CKD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lyon Sud University Hospital
Pierre-Bénite, Rhône, 69310, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Study links gum health to rare kidney diseases
- Tiny study probes urea breakdown in dialysis patients
- New stem cell therapy aims to restore kidney function in early trial
- Garlic supplement shows promise for dialysis patients
- Could this pill protect kidneys in diabetes?
- New drink flavors aim to help kidney patients stay nourished